Colorectal Cancer: Epidemiological Study, Clinical, Histological and Immunohistochemistry Examination in Patient of West Algeria — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Colorectal Cancer: Epidemiological Study, Clinical, Histological and Immunohistochemistry Examination in Patient of West Algeria
Laboratory of Biology of Development and Differanciation, Department of Biology, Faculty of Natural Science and Life, University of Oran 1 (Ahmed Benbella), Oran, Algeria
,
Laboratory of Biology of Development and Differanciation, Department of Biology, Faculty of Natural Science and Life, University of Oran 1 (Ahmed Benbella), Oran, Algeria
,
Laboratory of Biology of Development and Differanciation, Department of Biology, Faculty of Natural Science and Life, University of Oran 1 (Ahmed Benbella), Oran, Algeria
,
Laboratory of Biology of Development and Differanciation, Department of Biology, Faculty of Natural Science and Life, University of Oran 1 (Ahmed Benbella), Oran, Algeria
1 Laboratory of Biology of Development and Differanciation, Department of Biology, Faculty of Natural Science and Life, University of Oran 1 (Ahmed Benbella), Oran, Algeria
2 Laboratory of Biology of Development and Differanciation, Department of Biology, Faculty of Natural Science and Life, University of Oran 1 (Ahmed Benbella), Oran, Algeria
3 Laboratory of Biology of Development and Differanciation, Department of Biology, Faculty of Natural Science and Life, University of Oran 1 (Ahmed Benbella), Oran, Algeria
4 Laboratory of Biology of Development and Differanciation, Department of Biology, Faculty of Natural Science and Life, University of Oran 1 (Ahmed Benbella), Oran, Algeria
Colorectal cancer (CRC) is significant publichealth problem in rich countries of the world, because of its frequency and mostly because of its severity. Our aim was to improve histologic diagnosis of malignancy with topographic coloration (HE) and cytokeratins 7, 20 immuno-labeling. The risk for colorectal cancer incease with age, but in our series, 10% of colorectal cancer exist in patients younger than 40 years old. In histological study, adenocarcinoma represented 100% and the evaluation for stage of disease showed that the most dominant isstage IV (32.6%). In our trial, we found that cytokeratins 7 and 20 immunoreactivity in colorectal adenocarcinoma are often positive for cytokeratin-20 and most of time negative for cytokeratin-7.
KeywordsAdenocarcinomaColorectal Cancer (CRC)Cytokeratin (720)
Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2014) GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon. http://globocan.iarc.fr
Sedkaoui, C. (2015) Chemotherapy and Targeted Therapy in Metastatic Colorectal Cancer. Doctoral Thesis.
Kanthan, R., Senger, J.L. and Kanthan, S.C. (2012) Molecular Events in Primary and Metastatic Colorectal Carcinoma: A Review. Pathology Research International, 2012, Article ID: 597497.
Worthley, D.L. and Leggett, B.A. (2010) Colorectal Cancer: Molecular Features and Clinical Opportunities. The Clinical Biochemist Reviews, 31, 31-38.
Tinmouth, J., Baxter, N.N., Paszat, L.F., Rabeneck, L., Sutradhar, R. and Yun, L. (2014) Using Physician-Linked Mailed Invitations in an Organised Colorectal Cancer Screening Programme: Effectiveness and Factors Associated with Response. BMJ Open, 4, e004494. https://doi.org/10.1136/bmjopen-2013-004494
Fleming, M., Ravula, S., Tatishchev, S.F. and Wang, H.L. (2012) Colorectal Carcinoma: Pathologic Aspects. Journal of Gastrointestinal Oncology, 3, 153-173.
American Cancer Society (2016) Cancer Facts & Figures 2016. American Cancer Society, Atlanta.
GLOBOCAN (2000) Cancer Incidence, Mortality and Prevalence Worldwide. International Adgency for Research on Cancer European Network of Cancer Registers (IARC CancerBase No. 5).
Bayrak, R., Yenidünya, S. and Haltas, H. (2011) Cytokeratin 7 and Cytokeratin 20 Expression in Colorectal Adenocarcinomas. Pathology Research and Practice, 207, 156-160. https://doi.org/10.1016/j.prp.2010.12.005
Roncucci, L., Ponz de Leon, M., Scalmati, A., Malagoli, G., Pratissoli, S., Perini, M. and Chahin, N.J. (1988) The Influence of Age on Colonic Epithelial Cell Proliferation. Cancer, 62, 2373-2377. https://doi.org/10.1002/1097-0142(19881201)62:11 3.0.CO;2-Y
Park, S.Y., Kim, B.H., Kim, J.H., Lee, S. and Kang, G.H. (2007) Panels of Immuno-histochemical Markers Help Determine Primary Sites of Metastatic Adenocarcinoma. Archives of Pathology & Laboratory Medicine, 131, 1561-1567.
Center, M.M., Jemal, A. and Ward, E. (2009) International Trends in Colorectal Cancer Incidence Rates. Cancer Epidemiology, Biomarkers & Prevention, 18, 1688-1694. https://doi.org/10.1158/1055-9965.EPI-09-0090
Shah, S.A., Neoh, H.M., Rahim, S.S., Azhar, Z.I., Hassan, M.R., Safian, N. and Jamal, R. (2004) Spatial Analysis of Colorectal Cancer Cases in Kuala Lumpur. Asian Pacific Journal of Cancer Prevention, 15, 1149-1154.
Payne, S. (2007) Not An Equal Opportunity Disease—A Sex and Gender-Based Review of Colorectal Cancer in Men and Women: Part I. The Journal of Men’s Health & Gender, 4, 131-139. https://doi.org/10.1016/j.jmhg.2007.03.005
Deng, W., Long, L., Li, J.L., Zheng, D., Yu, J.H., Zhang, C.Y., Li, K.Z., Liu, H.Z. and Huang, T.R. (2014) Mortality of Major Cancers in Guangxi, China: Sex, Age and Geographical Differences from 1971 and 2005. Asian Pacific Journal of Cancer Prevention, 15, 1567-1574. https://doi.org/10.7314/APJCP.2014.15.4.1567
Holt, P.R., Kozuch, P. and Mewar, S. (2009) Colon Cancer and the Elderly: From Screening to Treatment in Management of GI Disease in the Elderly. Best Practice & Research Clinical Gastroenterology, 23, 889-907. https://doi.org/10.1016/j.bpg.2009.10.010
Bouassida, M., Bilel, F., Bassem, M., Mohamed, F.C., Selim, S., Fathi, C., Souheil, B., Mohamed, M.M., Hassen, T., Mohamed, M.A. and Sadok, S. (2012) Histopathologic Characteristics and Short-Term Outcomes of Colorectal Cancer in Young Tunisian Patients: One Center’s Experience. The Pan African Medical Journal, 12, 10.
Duval, J.V., Savas, L. and Banner, B.F. (2000) Expression of Cytokeratins 7 and 20 in Carcinomas of the Extrahepatic Biliary Tract, Pancreas, and Gallbladder. Archives of Pathology & Laboratory Medicine, 124, 1196-1200.
Varadhachary, G.R. (2007) Carcinoma of Unknown Primary Origin. Gastrointestinal Cancer Research, 1, 229-235.
Pavlidis, N., Briasoulis, E., Hainsworth, J. and Greco, F.A. (2003) Diagnostic and Therapeutic Management of Cancer of an Unknown Primary. European Journal of Cancer, 39, 1990-2005. https://doi.org/10.1016/S0959-8049(03)00547-1
Pecciarini, L., Cangi, M.G. and Doglioni, C. (2001) Identifying the Primary Sites of Metastatic Carcinoma: The Increasing Role of Immunohistochemistry. Current Diagnostic Pathology, 7, 168-175. https://doi.org/10.1054/cdip.2001.0079
Ramaekers, C., Van Niekerk, C., Poels, L., Schaafsma, E., Huijsmans, A., Robben, H., Schaart, G. and Vooijs, P. (1990) Use of Monoclonal Antibodies to Keratin7 in Differential Diagnosis of Adenocarcinomas. American Journal of Pathology, 136, 641-655.
Tot, T. (1999) Adenocarcinomas Metastatic to the Liver. The Value of Cytokeratins 20 and 7 in the Search for Unknown Primary Tumors. Cancer, 85, 171-177. https://doi.org/10.1002/(SICI)1097-0142(19990101)85:1 3.0.CO;2-V
Wang, N.P., Zee, S., Zarbo, R.J., Bacchi, C.E. and Gown, A.M. (1995) Coordinate Expression of Cytokeratins 7 and 20 Defines Unique Subsets of Carcinomas. Applied Immuno-histochemistry & Molecular Morphology, 3, 99-107.
Chu, P., Wu, E. and Weiss, L.M. (2000) Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases. Modern Pathology, 13, 962-972. https://doi.org/10.1038/modpathol.3880175
Park, S.Y., Kim, H.S., Hong, E.K. and Kim, W.H. (2002) Expression of Cytokeratins 7 and 20 in Primary Carcinomas of the Stomach and Colorectum and Their Value in the Differential Diagnosis of Metastatic Carcinomas to the Ovary. Human Pathology, 33, 1078-1085. https://doi.org/10.1053/hupa.2002.129422
Saad, R.S., Silverman, J.F., Khalifa, M.A. and Rowsell, C. (2009) CDX2, Cytokeratins 7 and 20 Immunoreactivity in Rectal Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology, 17, 196-201. https://doi.org/10.1097/PAI.0b013e31819268f2
Zhang, P.J., Shah, M., Spiegel, G.W. and Brooks, J.J. (2003) Cytokeratin 7 Immunoreactivity in Rectal Adenocarcinomas. Applied Immunohistochemistry & Molecular Morphology, 11, 306-310. https://doi.org/10.1097/00129039-200312000-00005